|
Alchemia Ltd - Company Profile Snapshot
| Company Profile: |
Alchemia Ltd |
| Ticker: |
ACL |
| Exchanges: |
SYD |
| 2009 Sales: |
n/a |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
AUSTRALIA |
| Employees: |
16 |
Business Description
Alchemia Ltd. The Group's principal activity is developing new human therapeutics based on its proprietary drug discovery and synthesis technologies. Its products include: Generic Fondaparinux, HA-irinotecan, The HyACT and Alchemia's Vast. The Group operates in Australia and the United States of America.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
